Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075860 | SCV000106877 | pathogenic | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Multifactorial likelihood analysis posterior probability >0.99 |
Color Diagnostics, |
RCV001183311 | SCV001349016 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-03-15 | criteria provided, single submitter | clinical testing | This variant causes a G to C nucleotide substitution at the -1 position of intron 9 of the MLH1 gene. Functional RNA studies have shown that this variant causes exon 10 skipping, resulting in premature truncation (PMID: 22949379, 26247049, 29706640). This variant has been reported in individuals affected with Lynch syndrome (PMID: 8571956, 2414824; DOI: 10.3343/lmo.2018.8.4.156). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of MLH1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. |
Invitae | RCV001388082 | SCV001588929 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2020-03-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MLH1 are known to be pathogenic (PMID: 15713769, 24362816). Based on a multifactorial likelihood algorithm using genetic, tumor, and functional data, this variant has been determined to have a high probability of being pathogenic (PMID: 22949379). This variant has been observed in individual(s) with clinical features of Lynch syndrome (PMID: 8571956). ClinVar contains an entry for this variant (Variation ID: 90369). This variant is not present in population databases (ExAC no frequency). This sequence change affects an acceptor splice site in intron 9 of the MLH1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. |
Mendelics | RCV002247470 | SCV002517618 | pathogenic | Muir-Torré syndrome | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003452771 | SCV004187335 | likely pathogenic | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-07-18 | criteria provided, single submitter | clinical testing | This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723644 | SCV001956508 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001723644 | SCV001969136 | pathogenic | not provided | no assertion criteria provided | clinical testing |